TP53 and hepatocellular carcinoma: It is likely that W4P LHB impairs the cell-cycle checkpoint at the G1/S phase by inhibiting the p53–p21 axis, which in turn may contribute to HCC by the accumulation of mutations due to the maintenance of genome stability.